Evidence map›Paper›PMID 28691435›Full record

ArticleJournal of the International AIDS Society2017

Clinical and public health implications of acute and early HIV detection and treatment: a scoping review.

Sarah E Rutstein, Jintanat Ananworanich, Sarah Fidler, Cheryl Johnson, Eduard J Sanders, Omar Sued, Asier Saez-Cirion, Christopher D Pilcher, Christophe Fraser, Myron S Cohen and 3 more

Open access · goldAbstract readScoping Review
In one paragraph

Article in Journal of the International AIDS Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed, 3 pooled it
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 3 syntheses or guidelines pooled it, 137 citations in OpenAlex.

  1. Early diagnosis of HIV/aids infection: concept analysis.Revista brasileira de enfermagem · 2023
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Human Immunodeficiency Virus (HIV)-1 Transmission Among Persons With Acute HIV-1 Infection in Malawi: Demographic, Behavioral, and Phylogenetic Relationships.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Trial
  8. Trial
  9. Article
  10. CD169 expression of CD14BMC infectious diseases · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 7 countries.

Sarah E RutsteinDepartment of Health Policy and Management, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Jintanat AnanworanichU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
Sarah FidlerDepartment of Medicine, Imperial College London, London, UK.
Cheryl JohnsonHIV Department, World Health Organization, Geneva, Switzerland.
Eduard J SandersDepartment of Global Health, University of Amsterdam, Amsterdam, The Netherlands.
Omar SuedFundación Huésped, Buenos Aires, Argentina.
Asier Saez-CirionInstitut Pasteur, HIV Inflammation and Persistance Unit, Paris, France.
Christopher D PilcherHIV/AIDS Division, University of California San Francisco, San Francisco, CA, USA.
Christophe FraserBig Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Myron S CohenDivision of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Marco VitoriaHIV Department, World Health Organization, Geneva, Switzerland.
Meg DohertyHIV Department, World Health Organization, Geneva, Switzerland.
Joseph D TuckerDivision of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
University of North Carolina at Chapel Hill · USWorld Health Organization · CHFundación Huésped · ARHenry M. Jackson Foundation · USImperial College London · GBInstitut Pasteur · FRLondon School of Hygiene & Tropical Medicine · GBOpen Data Institute · GBUniversity of Amsterdam · NLUniversity of California, San Francisco · US

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM008719 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DARVILLE, TONI, DESHMUKH, MOHANISH P · 1999 to 2023
$15.1M
Reaching Unaware Sexual and Social Contacts to Interrupt Ongoing HIV TransmissionR01AI114320 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MILLER, WILLIAM C, POWERS, KIMBERLY A · 2014 to 2017
$2.5M
Optimizing HIV Therapy: virological monitoring, adherence & cost-effectivenessF30MH098731 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUTSTEIN, SARAH E. · 2012 to 2016
$201k
JDT NIAID R21AI20549KWTRP at the Centre for Geographical Medicine Research-Kilifi #203077/Z/16/ZMedical Research Council MR/L00528X/1NIAID NIH HHS P30 AI050410NIAID NIH HHS R01 AI114320NIGMS NIH HHS T32 GM008719NIMH NIH HHS F30 MH098731Wellcome Trust 077092Wellcome Trust 203077/Z/16/ZWorld Health Organization 001
6 · The paper itself

Abstract

introductionThe unchanged global HIV incidence may be related to ignoring acute HIV infection (AHI). This scoping review examines diagnostic, clinical, and public health implications of identifying and treating persons with AHI.

methodsWe searched PubMed, in addition to hand-review of key journals identifying research pertaining to AHI detection and treatment. We focused on the relative contribution of AHI to transmission and the diagnostic, clinical, and public health implications. We prioritized research from low- and middle-income countries (LMICs) published in the last fifteen years. RESULTS AND DISCUSSION: Extensive AHI research and limited routine AHI detection and treatment have begun in LMIC. Diagnostic challenges include ease-of-use, suitability for application and distribution in LMIC, and throughput for high-volume testing. Risk score algorithms have been used in LMIC to screen for AHI among individuals with behavioural and clinical characteristics more often associated with AHI. However, algorithms have not been implemented outside research settings. From a clinical perspective, there are substantial immunological and virological benefits to identifying and treating persons with AHI - evading the irreversible damage to host immune systems and seeding of viral reservoirs that occurs during untreated acute infection. The therapeutic benefits require rapid initiation of antiretrovirals, a logistical challenge in the absence of point-of-care testing. From a public health perspective, AHI diagnosis and treatment is critical to: decrease transmission via viral load reduction and behavioural interventions; improve pre-exposure prophylaxis outcomes by avoiding treatment initiation for HIV-seronegative persons with AHI; and, enhance partner services via notification for persons recently exposed or likely transmitting.

conclusionsThere are undeniable clinical and public health benefits to AHI detection and treatment, but also substantial diagnostic and logistical barriers to implementation and scale-up. Effective early ART initiation may be critical for HIV eradication efforts, but widespread use in LMIC requires simple and accurate diagnostic tools. Implementation research is critical to facilitate sustainable integration of AHI detection and treatment into existing health systems and will be essential for prospective evaluation of testing algorithms, point-of-care diagnostics, and efficacious and effective first-line regimens.

Indexed as

Public HealthBehavior TherapyEarly DiagnosisHIV InfectionsHumansPoint-of-Care SystemsPre-Exposure ProphylaxisProspective Studiesacute HIV infectionantiretroviral therapydiagnosticsearly HIVguidelineslow- and middle-income countriesprimary HIV

Identifiers

PMID28691435
PMCPMC5515019
OpenAlexW2730742515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.